NSUN6 expression is associated with clinicopathological factors such as T stage and Ki67+ cell rate, with samples exhibiting low NSUN6 expression showing enrichment in cell cycle and G2M checkpoint, correlating with increased cell proliferation and tumor growth, thus suggesting NSUN6 as a potential marker for predicting tumor recurrence and patient survival. This evidence concerns the gene NSUN6 and neoplasm.